WilliamShieldsMD
Child Neurology • Los Angeles, CANeurodevelopmental Disabilities
Chief, Clinical Trials in Pediatric Neurology; Director, Pediatric Epilepsy Program; Member, The Ketogenic Diet Program; Professor Emeritus, Pediatrics; Pediatric Neurology, UCLA School of Medicine
Dr. Shields is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10833 Le Conte Ave
# 12-441
Los Angeles, CA 90095Phone+1 310-206-3952Fax+1 310-206-0209
Education & Training
University of Utah HealthResidency, Neurology, 1973 - 1976
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pediatrics, 1971 - 1973
University of Utah School of MedicineClass of 1971
Certifications & Licensure
CA State Medical License 1972 - 2023
UT State Medical License 1974 - 2022
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- 11 citationsWhich children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry.John M. Pellock, Edward Faught, Rod Foroozan, Robert C. Sergott, W. Donald Shields
Epilepsy & Behavior. 2016-07-01 - 14 citationsSabril® registry 5-year results: Characteristics of adult patients treated with vigabatrinGregory L. Krauss, Edward Faught, Rod Foroozan, John M. Pellock, Robert C. Sergott
Epilepsy & Behavior. 2016-03-01 - Unintended Consequences: The Story of PERFRoy D. Elterman, W. Donald Shields
Pediatric Neurology. 2015-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
